NEXT GENERATION SEQUENCING MARKET ANALYSIS

Next Generation Sequencing Market, By Product Type (Instruments, Reagents & Consumables), By Sequencing Type (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing, Others), By Application (Drug Discovery, Personalized Medicine, Genetic Screening, Diagnostics, Others), By End User (Hospitals & Clinics, Academic & Research Institutes, Biopharmaceutical Companies, Clinical Laboratories, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Mar 2024
Code : CMI158
Pages :156
Formats :
Excel and PDF
Industry : Biotechnology

Market Concentration and Competitive Landscape

Next Generation Sequencing Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing advancements in next generation sequencing procedures

Demand for DNA testing is increasing due to advancements in next generation sequencing instruments and technologies, faster results, and cost effectives of the process as compared to genotyping based DNA microarray. For instance, in January 2022, a new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic diseases in an average of eight hours. Genome sequencing allows scientists to see a patient’s complete DNA makeup, which contains information about everything from eye color to inherited diseases. Genome sequencing is vital for diagnosing patients with diseases rooted in their DNA.

Key Players Insights